AzTrials
AzTrials

Artery InjuryNCT03872323

Open and Endovascular Surgical Treatment for Artery Injuries

A study testing Endovascular treatment and Open surgery in people with Artery Injury, run by Jinan Military General Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Traumatic injuries of peripheral arteries are often associated with multiple injuries, massive hemorrhage, state of shock, and loss of blood supply, as well as with high mortality. Traditionally, an open surgical approach is suggested for the management of artery injury. Read more about this study

Who is it for?
Any age
Conditions the study is for
Artery Injury
What is being tested?
Endovascular treatment and Open surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteChina
Study dates
1 Apr 2019to 1 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Injuries in the peripheral arteries; Loss of blood supply to the remote area; High-risk emergency artery reconstruction; Participate in the study voluntarily, accept follow up study. -

Who cannot join

  • Bleeding can be easily control; There is contraindications for surgical operation. -

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • 960 Hospital of PLA

    Jinan, Shandong, 250031

    Min Li, M.D.

    Recruiting

Other trials in China

About this study

Official title: Comparison Between Open and Endovascular Surgical Techniques to Manage Vascular Injuries

Traumatic injuries of peripheral arteries are often associated with multiple injuries, massive hemorrhage, state of shock, and loss of blood supply, as well as with high mortality. Traditionally, an open surgical approach is suggested for the management of artery injury. With the advancement of endovascular techniques, the traditional open vascular exposure and vessel repair are no longer the only option available. The purpose of this study is to compare the effectiveness, long-term safety and explore the safety and efficacy factors between open and endovascular surgical techniques.

Conditions
Artery Injury
Being tested
Endovascular treatment, Open surgery
Keywords
Artery Injury, Surgery, Endovascular Repair, Peripheral Arteries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endovascular treatmentProcedure or surgery

    The arteries injuries are repaired by endovascular treatment.

  • Open surgeryProcedure or surgery

    The arteries injuries are repaired by open surgical operation.

Study groups in NCT03872323
Study groupRoleWhat they receive
Endovascular treatmentActive comparatorNot described
Receives: Procedure: Endovascular treatment
Open surgeryActive comparatorNot described
Receives: Procedure: Open surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 5-year treatment success rate

    Treatment success is defined as restored blood flow without clinical complications.

    Measured: 60 months

Secondary outcomes (5)
  1. Technically success rate of surgery

    Measured: immediately after surgery

  2. Surgery-related complications or death

    Measured: 60 months

  3. Currence of stenosis of target lesion

    Measured: 60 months

  4. Device-related serious adverse events

    Measured: 60 months

  5. Target lesion was treated by interventional or surgical therapy once again

    Measured: 60 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2019
  2. Study start1 Apr 2019 (estimated)
  3. Primary completion30 Apr 2024 (estimated)
  4. Study completion1 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03872323
Sponsor's protocol ID
960HP20190045
Status last verified
Mar 2019
First submitted
11 Mar 2019
Last updated
13 Mar 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Endovascular treatment and Open surgery in people with Artery Injury, run by Jinan Military General Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Min Li, M.D. (13953176057, liminyingxiang@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

5-year treatment success rate (time frame: 60 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in